News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elite Pharmaceuticals, Inc. (ELI) ECR Pharmaceuticals Launch Lodrane D(R) Allergy Product



9/27/2011 10:19:11 AM

NORTHVALE, N.J., Sept. 27, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceutical, Inc.'s ("Elite" or the "Company") (OTCBB:ELTP) and ECR Pharmaceuticals ("ECR"), a wholly owned subsidiary of Hi-Tech Pharmacal (Hi-Tech), announced today the launch of Lodrane D®. Lodrane D® is an immediate release formulation of brompheniramine maleate and pseudoephedrine HCl, an effective, low-sedating antihistamine combined with a decongestant.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES